- Home
- HKPD vs PRPH Comparison
HKPD vs PRPH Comparison
Compare HKPD & PRPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HKPD
- PRPH
- Stock Information
- Founded
- HKPD 2016
- PRPH 1989
- Country
- HKPD Hong Kong
- PRPH United States
- Employees
- HKPD N/A
- PRPH N/A
- Industry
- HKPD Other Pharmaceuticals
- PRPH Biotechnology: Pharmaceutical Preparations
- Sector
- HKPD Health Care
- PRPH Health Care
- Exchange
- HKPD Nasdaq
- PRPH Nasdaq
- Market Cap
- HKPD 20.9M
- PRPH 17.7M
- IPO Year
- HKPD 2025
- PRPH 1997
- Fundamental
- Price
- HKPD $1.32
- PRPH $0.47
- Analyst Decision
- HKPD
- PRPH
- Analyst Count
- HKPD 0
- PRPH 0
- Target Price
- HKPD N/A
- PRPH N/A
- AVG Volume (30 Days)
- HKPD 161.5K
- PRPH 930.1K
- Earning Date
- HKPD 01-01-0001
- PRPH 08-13-2025
- Dividend Yield
- HKPD N/A
- PRPH N/A
- EPS Growth
- HKPD N/A
- PRPH N/A
- EPS
- HKPD 0.21
- PRPH N/A
- Revenue
- HKPD $20,770,344.00
- PRPH $5,845,000.00
- Revenue This Year
- HKPD N/A
- PRPH $221.82
- Revenue Next Year
- HKPD N/A
- PRPH N/A
- P/E Ratio
- HKPD $6.18
- PRPH N/A
- Revenue Growth
- HKPD 32.91
- PRPH N/A
- 52 Week Low
- HKPD $0.81
- PRPH $0.22
- 52 Week High
- HKPD $3.79
- PRPH $3.37
- Technical
- Relative Strength Index (RSI)
- HKPD N/A
- PRPH 63.66
- Support Level
- HKPD N/A
- PRPH $0.32
- Resistance Level
- HKPD N/A
- PRPH $0.45
- Average True Range (ATR)
- HKPD 0.00
- PRPH 0.04
- MACD
- HKPD 0.00
- PRPH 0.00
- Stochastic Oscillator
- HKPD 0.00
- PRPH 90.27
About HKPD Hong Kong Pharma Digital Technology Holdings Limited Ordinary shares
Hong Kong Pharma Digital Technology Holdings Ltd operates in two main categories: (i) OTC pharmaceutical cross-border e-commerce supply chain services, conducted through its Hong Kong subsidiary, Joint Cross Border, which it refers to as the Supply Chain Services division, and (ii) OTC pharmaceutical cross-border procurement and distribution, conducted through its Hong Kong subsidiary, V-Alliance, which it referred to as the Procurement and Distribution division. Based in Hong Kong, Joint Cross Border has established itself as a provider of third-party supply chain services in Mainland China's OTC pharmaceutical cross-border e-commerce market.
About PRPH ProPhase Labs Inc. (DE)
ProPhase Labs Inc is a diversified company offering various services, including diagnostic testing, genomics testing, and contract manufacturing. Its operating segments include Diagnostic services and Consumer products. The Diagnostic segment provides COVID-19 diagnostic information services to a broad range of customers in the United States, including health plans, third-party payers, and government organizations. The Consumer Products segment is engaged in the research, development, manufacture, distribution, marketing, and sale of OTC consumer healthcare products and dietary supplements in the United States. It also provides personal genomics products and services.